BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Murphy EL, Fang J, Tu Y, Cable R, Hillyer CD, Sacher R, Triulzi D, Gottschall JL, Busch MP; Retrovirus Epidemiology Donor Study. Hepatitis C virus prevalence and clearance among US blood donors, 2006-2007: associations with birth cohort, multiple pregnancies, and body mass index. J Infect Dis 2010;202:576-84. [PMID: 20617929 DOI: 10.1086/654882] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Lee MH, Yang HI, Lu SN, Lin YJ, Jen CL, Wong KH, Chan SY, Chen LC, Wang LY, L'Italien G, Yuan Y, Chen CJ. Polymorphisms near the IFNL3 Gene Associated with HCV RNA Spontaneous Clearance and Hepatocellular Carcinoma Risk. Sci Rep 2015;5:17030. [PMID: 26602024 DOI: 10.1038/srep17030] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
2 Vieira PCM, Lamarão LM, Amaral CEM, Corrêa ASM, de Lima MSM, Barile KADS, de Almeida KLD, Sortica VA, Kayath AS, Burbano RMR. Residual risk of transmission of human immunodeficiency virus and hepatitis C virus infections by blood transfusion in northern Brazil. Transfusion 2017;57:1968-76. [PMID: 28589643 DOI: 10.1111/trf.14146] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
3 Tulio S, Faucz FR, Werneck RI, Olandoski M, Alexandre RB, Boldt AB, Pedroso ML, de Messias-Reason IJ. MASP2 gene polymorphism is associated with susceptibility to hepatitis C virus infection. Hum Immunol. 2011;72:912-915. [PMID: 21843573 DOI: 10.1016/j.humimm.2011.06.016] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
4 Selvarajah S, Tobler LH, Simmons G, Busch MP. Host genetic basis for hepatitis C virus clearance: a role for blood collection centers. Curr Opin Hematol 2010;17:550-7. [PMID: 20729732 DOI: 10.1097/MOH.0b013e32833e7544] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
5 Sheikh MY, Atla PR, Ameer A, Sadiq H, Sadler PC. Seroprevalence of Hepatitis B and C Infections among Healthy Volunteer Blood Donors in the Central California Valley. Gut Liver 2013;7:66-73. [PMID: 23423771 DOI: 10.5009/gnl.2013.7.1.66] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
6 Kufa T, Chihota V, Mngomezulu V, Charalambous S, Verver S, Churchyard G, Borgdorff M. The incidence of tuberculosis among hiv-positive individuals with high CD4 counts: implications for policy. BMC Infect Dis 2016;16:266. [PMID: 27286814 DOI: 10.1186/s12879-016-1598-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
7 Greenaway C, Thu Ma A, Kloda LA, Klein M, Cnossen S, Schwarzer G, Shrier I. The Seroprevalence of Hepatitis C Antibodies in Immigrants and Refugees from Intermediate and High Endemic Countries: A Systematic Review and Meta-Analysis. PLoS One. 2015;10:e0141715. [PMID: 26558905 DOI: 10.1371/journal.pone.0141715] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 6.7] [Reference Citation Analysis]
8 Altınbas S, Holmes JA, Altınbas A. Hepatitis C Virus Infection in Pregnancy: An Update. Gastroenterol Nurs 2020;43:12-21. [PMID: 31990870 DOI: 10.1097/SGA.0000000000000404] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
9 Lai JC, O’Leary JG, Trotter JF, Verna EC, Brown RS, Stravitz RT, Duman JD, Forman LM, Terrault NA. Risk of advanced fibrosis with grafts from hepatitis C antibody-positive donors: a multicenter cohort study. Liver Transpl. 2012;18:532-538. [PMID: 22271671 DOI: 10.1002/lt.23396] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 4.5] [Reference Citation Analysis]
10 El-Ghitany EM, Farghaly AG, Abdel Wahab MM, Farag S, Abd El-Wahab EW. Toward a simple risk assessment screening tool for HCV infection in Egypt. J Med Virol 2016;88:1767-75. [PMID: 26970264 DOI: 10.1002/jmv.24520] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
11 Cartwright EJ, Rentsch C, Rimland D. Hepatitis C virus screening practices and seropositivity among US veterans born during 1945 - 1965. BMC Res Notes 2014;7:449. [PMID: 25023159 DOI: 10.1186/1756-0500-7-449] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
12 López-Osorio MC, Beltrán M, Navas MC. [Epidemiology of hepatitis C virus infection in ColombiaEpidemiologia da infecção pelo vírus da hepatite C na Colômbia]. Rev Panam Salud Publica 2021;45:e96. [PMID: 34539763 DOI: 10.26633/RPSP.2021.96] [Reference Citation Analysis]
13 Xu R, Yu Y, Leitch ECM, Wang M, Huang K, Huang J, Tang X, Liao Q, Song D, Shan Z, Li C, Mclauchlan J, Rong X. HCV genotype 6 prevalence, spontaneous clearance and diversity among elderly members of the Li ethnic minority in Baisha County, China. J Viral Hepat 2019;26:529-40. [PMID: 30629794 DOI: 10.1111/jvh.13062] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
14 Durier N, Yunihastuti E, Ruxrungtham K, Kinh NV, Kamarulzaman A, Boettiger D, Widhani A, Avihingsanon A, Huy BV, Syed Omar SF, Sanityoso A, Chittmittrapap S, Dung NT, Pillai V, Suwan-Ampai T, Law M, Sohn AH, Matthews G. Chronic hepatitis C infection and liver disease in HIV-coinfected patients in Asia. J Viral Hepat 2017;24:187-96. [PMID: 27917597 DOI: 10.1111/jvh.12630] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
15 Pandit DP, Pagaro M P, Nabamita C. Prevalence of antibodies to hepatitis C virus in voluntary blood donors: are women better donors? J Clin Diagn Res 2014;8:DC20-3. [PMID: 24959444 DOI: 10.7860/JCDR/2014/7575.4295] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Li T, Chen Z, Zeng J, Zhang J, Wang W, Zhang L, Zheng X, Shuai L, Klenerman P, Allain JP, Li C. Impact of host responses on control of hepatitis C virus infection in Chinese blood donors. Biochem Biophys Res Commun 2011;415:503-8. [PMID: 22062549 DOI: 10.1016/j.bbrc.2011.10.102] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
17 Nagalo MB, Sanou M, Bisseye C, Kaboré MI, Nebie YK, Kienou K, Kiba A, Dahourou H, Ouattara S, Zongo JD, Simporé J. Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis among blood donors in Koudougou (Burkina Faso) in 2009. Blood Transfus 2011;9:419-24. [PMID: 21839011 DOI: 10.2450/2011.0112-10] [Cited by in F6Publishing: 35] [Reference Citation Analysis]
18 Frontini M, Chotalia J, Spizale L, Onya W, Ruiz M, Clark RA. Sex and race effects on risk for selected outcomes among elderly HIV-infected patients. J Int Assoc Physicians AIDS Care (Chic) 2012;11:12-5. [PMID: 21518853 DOI: 10.1177/1545109711404947] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
19 Aisyah DN, Shallcross L, Hully AJ, O'Brien A, Hayward A. Assessing hepatitis C spontaneous clearance and understanding associated factors-A systematic review and meta-analysis. J Viral Hepat 2018;25:680-98. [PMID: 29345844 DOI: 10.1111/jvh.12866] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
20 Cardona Arias JA, Flórez Duque J, Higuita Gutiérrez LF. Seroprevalencia del virus de la hepatitis C en un banco de sangre de Medellín-Colombia, 2005-2018. Acta biol Colomb 2019;24:486-92. [DOI: 10.15446/abc.v24n3.79399] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Lappas M. Double stranded viral RNA induces inflammation and insulin resistance in skeletal muscle from pregnant women in vitro. Metabolism 2015;64:642-53. [PMID: 25707553 DOI: 10.1016/j.metabol.2015.02.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
22 Kleinman S, King MR, Busch MP, Murphy EL, Glynn SA; National Heart Lung Blood Institute Retrovirus Epidemiology Donor Study., Retrovirus Epidemiology Donor Study-II. The National Heart, Lung, and Blood Institute retrovirus epidemiology donor studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II): twenty years of research to advance blood product safety and availability. Transfus Med Rev 2012;26:281-304, 304.e1-2. [PMID: 22633182 DOI: 10.1016/j.tmrv.2012.04.004] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]